Joint and Soft Tissue Injections: Difference between revisions
(Created page with "It has long been recognised that injecting corticosteroids locally at a site of inflammation is superior to large oral doses. == Indications == Corticosteroid injection c...") ย |
|||
Line 20: | Line 20: | ||
== Contraindications == | == Contraindications == | ||
* | * Infection | ||
* | * Intra-articular fracture | ||
* Haemarthrosis | * Haemarthrosis | ||
* Patient reluctance or other psychological issues | * Patient reluctance or other psychological issues | ||
* Before a specific diagnosis is made (relative contraindication) | * Before a specific diagnosis is made (relative contraindication) | ||
* Late stage joint disease with irreparable mechanical damage (relative contraindication) | * Late stage joint disease with irreparable mechanical damage (relative contraindication) | ||
* Prosthetic or unstable joint | |||
== Frequency == | == Frequency == | ||
Line 43: | Line 43: | ||
'''Methylprednisolone''' (Depomedrol){{NZF|code=3843}}: useful alternative, preferred for superficial injections. | '''Methylprednisolone''' (Depomedrol){{NZF|code=3843}}: useful alternative, preferred for superficial injections. | ||
'''Dexamethasone''': this is more commonly used for epidural injections. | |||
{| class="wikitable" | {| class="wikitable" | ||
|+Doses | |+Doses | ||
Line 54: | Line 56: | ||
|Triamcinolone 40mg | |Triamcinolone 40mg | ||
Methylprednisolone 40mg | Methylprednisolone 40mg | ||
Dexamethasone 6mg | |||
|22G | |22G | ||
|- | |- | ||
Line 60: | Line 64: | ||
|Triamcinolone 20mg | |Triamcinolone 20mg | ||
Methylprednisolone 20mg | Methylprednisolone 20mg | ||
Dexamethasone 3mg | |||
|23G | |23G | ||
|- | |- | ||
Line 66: | Line 72: | ||
|Triamcinolone 10-20mg | |Triamcinolone 10-20mg | ||
Methylprednisolone 10-20mg | Methylprednisolone 10-20mg | ||
Dexamethasone 1.5mg | |||
|25G 1" | |25G 1" | ||
|} | |} | ||
Line 90: | Line 98: | ||
** Pre-packaged sterilised disposable needles and syringes | ** Pre-packaged sterilised disposable needles and syringes | ||
** Single dose ampoules of local anaesthetic and steroid | ** Single dose ampoules of local anaesthetic and steroid | ||
** Swab injection site with chlorhexidine or chlorhexidine + | ** Swab injection site with chlorhexidine or chlorhexidine + alcohol mixture | ||
** No touch technique after swabbing | ** No touch technique after swabbing | ||
* Aspirate any synovial fluid (use 10mL syringe for large joints). Send for routine analysis of cell count, crystals, and culture in a pink pottle and purple top tube. | * Aspirate any synovial fluid (use 10mL syringe for large joints). Send for routine analysis of cell count, crystals, and culture in a pink pottle and purple top tube. |
Revision as of 04:57, 7 March 2022
It has long been recognised that injecting corticosteroids locally at a site of inflammation is superior to large oral doses.
Indications
Corticosteroid injection can be considered when there are few joints affected in the context of active inflammation. It is also useful in joint involvement that is preventing active rehabilitation
For soft tissues it can be considered in pain that is unresponsive to other measures - NSAIDs, physical therapy (See Tendinopathy Management), time, etc.
- Joints
- Chronic inflammatory joint disease
- Rheumatoid arthritis
- Spondyloarthritis
- Crystal arthritis - gout/pseudogout
- Traumatic synovitis
- Osteoarthritis - acute flare
- Soft tissues
- Enthesopathies
- Tensosynovitis, bursitis
- Compression neuropathies - e.g. carpal tunnel syndrome
Contraindications
- Infection
- Intra-articular fracture
- Haemarthrosis
- Patient reluctance or other psychological issues
- Before a specific diagnosis is made (relative contraindication)
- Late stage joint disease with irreparable mechanical damage (relative contraindication)
- Prosthetic or unstable joint
Frequency
Injections should be done as infrequently as possible.
In inflammatory arthritis a maximum of 3-4 per individual joint per year, at least four weeks apart, and no more than 2-3 joints in one sitting.
For soft tissues maximum 3 at least one month apart per year depending on response. If no response after two injections do not continue and consider alternative treatment
Corticosteroids
Long acting corticosteroids are preferred
Triamcinolone acetonide (Kenacort-A): A10 (10mg/ml) low dose, A40 (40mg/ml) high dose. Intra-articular and deep soft tissue injections. Caution with superficial injection e.g. lateral elbow tendinopathy due to tissue atrophy.
Triamcinolone hexacetonide: particularly good for children where it is a first line intraarticular steroid.
Methylprednisolone (Depomedrol): useful alternative, preferred for superficial injections.
Dexamethasone: this is more commonly used for epidural injections.
Joint | Dose | Needle | |
---|---|---|---|
Large Joints | Knee, shoulder | Triamcinolone 40mg
Methylprednisolone 40mg Dexamethasone 6mg |
22G |
Medium Joints | Ankle, elbow | Triamcinolone 20mg
Methylprednisolone 20mg Dexamethasone 3mg |
23G |
Small Joints | Hands, feet, wrist, superficial soft tissues | Triamcinolone 10-20mg
Methylprednisolone 10-20mg Dexamethasone 1.5mg |
25G 1" |
Local Anaesthetic
Using a local anaesthetic such as lidocaine 1% is often mixed with corticosteroid. For larger joints it allows for creating a greater volume for distribution. It can ease post-injection pain. It is useful in determining whether the injection was given to the correct area. Smaller joints do not allow for much local anaesthetic to be used.
Complications
- Post-injection flare
- Infection - rare 1/50,000
- Acute crystal synovitis
- Skin atrophy
- Tendon rupture
- Allergic reaction
Technique
- Have the patient in a relaxed position
- Doctor also in a relaxed position such as sitting down
- Identify the injection site by palpation and landmarks or with ultrasound guidance
- Use strict aseptic technique
- Wash hands
- Pre-packaged sterilised disposable needles and syringes
- Single dose ampoules of local anaesthetic and steroid
- Swab injection site with chlorhexidine or chlorhexidine + alcohol mixture
- No touch technique after swabbing
- Aspirate any synovial fluid (use 10mL syringe for large joints). Send for routine analysis of cell count, crystals, and culture in a pink pottle and purple top tube.
- Do not inject against resistance, this usually means it isn't in the right place for example within a tendon
- After injection move joint gently to disperse the injectate throughout the joint
Post-Advice
Advise that the joint may be painful for up to 24 hours post injection, and it may take several days to a week for the full benefit. The injected site should be rested for 24 hours with no heavy lifting or excessive walking. No sporting activity for at least 5 days. Supportive splints are sometimes needed.
Follow up
Contact again in the next few days to assess response and ensure no complications.
If failure to respond this could mean technical failure or a non-inflammatory condition.
References
Courtney P, Doherty M. Joint aspiration and injection. Best Pract Res Clin Rheumatol. 2005 Jun;19(3):345-69. doi: 10.1016/j.berh.2005.01.009. PMID: 15939363.
Speed CA. Injection therapies for soft-tissue lesions. Best Pract Res Clin Rheumatol. 2007 Apr;21(2):333-47. doi: 10.1016/j.berh.2006.11.001. PMID: 17512486.
Stephens MB, Beutler AI, O'Connor FG. Musculoskeletal injections: a review of the evidence. Am Fam Physician. 2008 Oct 15;78(8):971-6. PMID: 18953975.